Subscribe

What are you looking for?

Main Menu

明報新聞網

莫德納黑色素瘤疫苗研究成功股價升逾倍 港mRNA股大升

Future Wealths
Future Wealths
20 8 月, 2026
One Min Read
1 Views
0 Comments
彭博報道，在一項大型後期臨牀試驗中，由莫德納(Moderna)和默克(Merck)研發的一款個性化疫苗幫助降低了黑色素瘤復發風險，提高了外界對治療這種致死率最高的皮膚癌的期望，也顯示出目前面臨質疑的mRNA技術所具有的潛力。

原文: https://finance.mingpao.com/fin/instantf/20260820/1787191764120/%E8%8E%AB%E5%BE%B7%E7%B4%8D%E9%BB%91%E8%89%B2%E7%B4%A0%E7%98%A4%E7%96%AB%E8%8B%97%E7%A0%94%E7%A9%B6%E6%88%90%E5%8A%9F%E8%82%A1%E5%83%B9%E5%8D%87%E9%80%BE%E5%80%8D-%E6%B8%AFmrna%E8%82%A1%E5%A4%A7%E5%8D%87%22%20target=%22blank

Last Update: 20 8 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept